Powder: -20°C for 3 years | In solvent: -80°C for 1 year
FCPR03 is a selective inhibitor of phosphodiesterase 4 (PDE4) with IC50s of 31 nM, 47 nM, and 60 nM for PDE4B1, PDE4D7, and PDE4 catalytic domain, respectively. FCPR03 has neuroprotective, anti-inflammatory, and antidepressant-like effects.
説明 | FCPR03 is a selective inhibitor of phosphodiesterase 4 (PDE4) with IC50s of 31 nM, 47 nM, and 60 nM for PDE4B1, PDE4D7, and PDE4 catalytic domain, respectively. FCPR03 has neuroprotective, anti-inflammatory, and antidepressant-like effects. |
ターゲット&IC50 | PDE4D7:47 nM (IC50), PDE4B1:31 nM (IC50), PDE4 catalytic domain:60 nM (IC50) |
分子量 | 299.31 |
分子式 | C15H19F2NO3 |
CAS No. | 1917347-65-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 95 mg/mL (317.40 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
FCPR03 1917347-65-9 Metabolism PDE antidepressant-like PDE4B1 PDE4D7 FCPR-03 PDE4 neuroprotective ischemic AKT GSK3β FCPR 03 inhibit anti-inflammatory Phosphodiesterase (PDE) β-catenin Inhibitor stroke inhibitor